The effect of propolis supplementation in hemodialysis patients

Not Applicable

Recruiting

• Conditions: End stage renal disease.; Chronic kidney disease, stage 5; N18.5

• Registration Number: IRCT20220102053595N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

An age range of 18 to 65 years
ESRD patients on hemodialysis treatment
Perform hemodialysis 3 days a week
Absence of any physical abnormalities or bone diseases that interfere with their physical activity
Willingness to participate in research

Exclusion Criteria

BMI above 30 kg/m
Disease (gallstones, cancer, and acute disease)
Acute heart accident in the past year
Taking any medicine outside the routine treatment protocol of hemodialysis patients
Use of oral and injectable nutritional supplements except nephrovit and iron supplements according to the protocol
Any allergy to honey and its compounds
Leaving the patient with his/her personal consent
Smoking, drug addiction or alcohol consumption

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Malondialdehyde. Timepoint: At the beginning and end of the study. Method of measurement: kit.;Total antioxidant capacity. Timepoint: At the beginning and end of the study. Method of measurement: kit.;Systolic blood pressure. Timepoint: At the beginning and end of the study. Method of measurement: Mercury manometers.;Diastolic blood pressure. Timepoint: At the beginning and end of the study. Method of measurement: Mercury manometers.;Nutritional status. Timepoint: At the beginning and end of the study. Method of measurement: Food recall and 3-day food record questionnaires.;Anthropometric indicators. Timepoint: At the beginning and end of the study. Method of measurement: Weighing scale, Tape measure, BIA.